As gene therapy programs advance toward commercialization, manufacturing decisions made early can have a lasting impact on product quality, scalability, and regulatory success. In this virtual event, leading CDMOs share...
Once a fringe idea in chemical biology, targeted protein degradation (TPD) has become one of the most watched strategies in drug discovery. TPD has created new therapeutic opportunities for previously...
Discover how innovative media design strategies can help overcome productivity limitations in bioprocessing and drive higher titers without sacrificing product quality. In this webinar, experts will share a data-driven, bottom-up...
Residual host cell DNA (residual DNA) is a critical quality attribute across biologics, vaccines and advanced therapy modalities, requiring sensitive and reproducible quantification to support process development, in-process control and...
The discussion will examine key manufacturing challenges and highlight where consumables add value, where they introduce unnecessary complexity, and how early upstream and downstream decisions impact long-term cost, scalability, and...
Rising regulatory expectations and increased scrutiny around particulate contamination are reshaping how risk is managed in bioprocessing. Particulate issues are often identified late in the process, leading to operational disruption,...
What does it take to turn breakthrough biology into successful in vivo therapies? As innovations in synthetic biology, RNA editing, and gene therapy continue to accelerate, vector design and manufacturing...
In some ways, it has been a quiet(er) year on the regulatory front for mRNA; there have been no mRNA-specific guidances released since the MHRA personalized cancer immunotherapy guidance and...
As biologics, complex injectables, and stricter regulatory requirements reshape sterile manufacturing, facility design has become a critical factor in operational success. In this webinar, learn how purpose-built modular aseptic filling...
Join Good Days, MassBio, and leaders from across healthcare, biotechnology, patient advocacy, and public policy for a focused discussion on advancing innovation and improving access for people living with chronic...
